KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Astrazeneca (AZN) Debt Ratio (2016 - 2025)

Astrazeneca has reported Debt Ratio over the past 11 years, most recently at 0.24 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.24 for Q4 2025, down 12.04% from a year ago — trailing twelve months through Dec 2025 was 0.24 (down 12.04% YoY), and the annual figure for FY2025 was 0.24, down 12.04%.
  • Debt Ratio for Q4 2025 was 0.24 at Astrazeneca, down from 0.28 in the prior quarter.
  • Over the last five years, Debt Ratio for AZN hit a ceiling of 286.48 in Q4 2021 and a floor of 0.24 in Q4 2025.
  • Median Debt Ratio over the past 5 years was 0.29 (2022), compared with a mean of 75.03.
  • Biggest five-year swings in Debt Ratio: crashed 99.9% in 2022 and later surged 29869.56% in 2023.
  • Astrazeneca's Debt Ratio stood at 286.48 in 2021, then crashed by 99.9% to 0.29 in 2022, then surged by 29869.56% to 87.84 in 2023, then crashed by 99.68% to 0.28 in 2024, then decreased by 12.04% to 0.24 in 2025.
  • The last three reported values for Debt Ratio were 0.24 (Q4 2025), 0.28 (Q4 2024), and 87.84 (Q4 2023) per Business Quant data.